ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NITE Nightstar Therapeutics Plc ADS

25.41
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nightstar Therapeutics Plc ADS NASDAQ:NITE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 25.41 18.50 25.41 0 01:00:00

Houlihan Lokey and Knight Form Joint Marketing Alliance

18/05/2010 11:05am

Business Wire


Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart


From Sep 2019 to Sep 2024

Click Here for more Nightstar Therapeutics Plc ADS Charts.

Houlihan Lokey, an international investment bank, today announced a joint marketing alliance with Knight Capital Group, Inc. (Nasdaq: NITE), a leading provider of market access and trade execution services across multiple asset classes.

Houlihan Lokey and Knight will team up to provide investment banking, capital markets and sales and trading services to their clients. Houlihan Lokey offers the industry-driven expertise of its investment banking division and its experience in developing financing solutions through a detailed understanding of its clients’ industries and capital structures. Knight brings deep and broad capabilities in distribution and trading, leveraging its position as a leading liquidity provider to institutional and retail investors. Together, the two firms will work to deliver world-class capital markets capability, focused on equity and fixed-income underwriting.

“By joining Knight’s distribution prowess with Houlihan Lokey’s independent investment banking advice, this alliance allows us each to focus on what we do best,” said Scott Adelson, Senior Managing Director and Co-Head of Corporate Finance at Houlihan Lokey. “We looked at other options for entering the distribution business and everything else paled in comparison. Knight is the best at what they do, and we are the best at what we do. It’s a powerful combination.”

“The alliance between Houlihan Lokey and Knight is a great example of two firms, each playing to their strengths, working together to deliver an outstanding result,” said Thomas Joyce, Chairman and Chief Executive Officer of Knight Capital. “It is a strategic and cost effective move to provide Houlihan Lokey clients with expanded distribution and Knight clients with access to new issues.”

About Houlihan Lokey

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm is ranked globally as the No. 1 restructuring advisor, the No. 1 M&A fairness opinion advisor over the past 10 years, and the No. 1 M&A advisor for U.S. transactions under $3 billion, according to Thomson Reuters. Houlihan Lokey has 14 offices and more than 800 employees in the United States, Europe and Asia. The firm serves more than 1,000 clients each year, ranging from closely held companies to Global 500 corporations. For more information, visit www.HL.com.

About Knight

Knight Capital Group, Inc. (Nasdaq: NITE) is a global financial services firm that provides market access and trade execution services across multiple asset classes to buy- and sell-side firms. Knight's hybrid market model features complementary electronic and voice trade execution services in global equities and fixed income as well as foreign exchange, futures and options. The firm is the leading source of liquidity in U.S. equities by share volume. Knight also offers capital markets services to corporate issuers. Knight is headquartered in Jersey City, NJ with a growing global presence across North America, Europe and the Asia-Pacific region. For more information, please go to www.knight.com.

1 Year Nightstar Therapeutics Plc ADS Chart

1 Year Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart